Telo Genomics Corp's total assets for Q2 2026 were C$337.79K, a decrease of -62.93% from the previous quarter. TSE:TELO total liabilities were C$891.12K for the fiscal quarter, a 124.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.